Table 2.

Significant Predictors of Clinical Outcome at 7 days and 90 days.

Variables	p value	95% CI
Positive DWI, n = 387 (39.2%)
7 days
Gender	0.989	0.995 (0.532–1.863)
Smoking	0.343	0.706 (0.343–1.450)
Hypertension history	0.051	2.005 (0.998–4.026)
Hyperlipemia history	0.593	1.261 (0.539–2.953)
ABCD2 ≥ 4	0.008	2.413 (1.256–4.638)
Anti-hypertension therapy	0.131	1.610 (0.868–2.987)
Anti-diabetes therapy	0.910	0.953 (0.417–2.180)
Dual antiplatelet therapy	0.436	0.776 (0.409–1.471)
HST	0.002	0.331 (0.165–0.663)
90 days
Gender	0.464	1.196 (0.741–1.929)
Smoking	0.194	0.694 (0.400–1.204)
Hypertension history	0.006	2.098 (1.232–3.573)
Hyperlipemia history	0.634	1.171 (0.612–2.240)
ABCD2 ≥ 4	0.014	1.836 (1.129–2.985)
Anti-hypertension therapy	0.174	1.394 (0.863–2.252)
Anti-diabetes therapy	0.951	1.020 (0.544–1.913)
Dual antiplatelet therapy	0.095	0.656 (0.400–1.077)
HST	0.005	0.480 (0.288–0.799)
Negative DWI, n = 600 (60.8%)
7 days
Gender	0.323	0.508 (0.133–1.945)
Smoking	0.427	0.532 (0.112–2.528)
Hypertension history	0.594	0.713 (0.206–2.474)
Hyperlipemia history	0.344	1.932 (0.495–7.546)
ABCD2 ≥ 4	0.433	1.637 (0.477–5.615)
Anti-hypertension therapy	0.214	0.375 (0.080–1.763)
Anti-diabetes therapy	0.654	0.621 (0.077–4.979)
Dual antiplatelet therapy	0.362	0.517 (0.125–2.133)
HST	0.672	0.750 (0.198–2.845)
90 days
Gender	0.340	0.660 (0.281–1.550)
Smoking	0.743	0.855 (0.334–2.186)
Hypertension history	0.215	1.739 (0.725–4.167)
Hyperlipemia history	0.641	0.772 (0.260–2.290)
ABCD2 ≥ 4	0.159	1.793 (0.796–4.040)
Anti-hypertension therapy	0.186	0.534 (0.211–1.354)
Anti-diabetes therapy	0.425	0.552 (0.129–2.374)
Dual antiplatelet therapy	0.595	0.795 (0.342–1.852)
HST	0.352	1.499 (0.639–3.515)

DWI: diffusion weighted imaging; AF: atrial fibrillation; HST: high-intensity statin therapy.